乳酸脱酶抑制剂的专利审查 (2014年至今)
Giulia Bononi1, Valeria Di Bussolo1, Tiziano Tuccinardi1
1Department of Pharmacy, University of Pisa, Pisa, Italy.
Expert opinion on therapeutic patents
|October 3, 2024
概括
乳酸脱酶 (LDH) 抑制剂对于向癌症进展和转移至关重要. 最近的专利揭示了各种各样的化合物,突出了正在进行的研究,用于治疗人类和动物的各种疾病.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 药用化学 医学化学
背景情况:
- 乳酸脱酶 (LDH) 是糖解中的一个关键酶,影响酸盐-乳酸盐的转化.
- 乳酸盐水平升高与瘤进展,转移以及包括心血管和神经退行性疾病在内的各种病理有关.
- 抑制LDH是癌症和其他疾病的有希望的治疗策略.
研究的目的:
- 对乳酸脱酶 (LDH) 抑制剂及其治疗应用的专利进行审查.
- 总结一下自2014年以来LDH抑制剂开发的最新进展.
主要方法:
- 在 Espacenet 数据库中搜索专利文献.
- 对2014年至今出版的专利进行分析.
- 对已识别的LDH抑制剂及其潜在治疗用途的审查.
主要成果:
- 识别各种新型化学物质类别和优化LDH抑制剂的衍生物.
- 作为人类和动物疾病的可行的治疗策略,LDH抑制的证明.
- 显著的学术和工业界对开发有效的LDH抑制剂的兴趣.
结论:
- LDH 抑制剂代表了瘤学和其他病理状况的有前途的治疗途径.
- 持续的专利活动强调了持续的科学重点是发现强效和选择性的LDH抑制剂.
- 对新型LDH抑制剂的进一步研究对于各种治疗应用是有必要的.
更多相关视频
05:38The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model
Published on: April 12, 2024
275
09:34The Lactate Dehydrogenase Sequestration Assay — A Simple and Reliable Method to Determine Bulk Autophagic Sequestration Activity in Mammalian Cells
Published on: July 27, 2018
18.1K
相关概念视频
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Electron Transport Chain: Complex I and II
12.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.1K
ATP Synthase: Mechanism
14.0K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.0K
